Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Miller

Showing results (181-190 of 235) with videos related to

Pageof 24
Sort By:
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Cell Reports|September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary CarcinomasObi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Clonal Hematopoiesis and Risk of Incident Lung CancerRuiyi Tian, Brian Wiley, Jie Liu, et al.
Leukemia|February 28, 2018
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignanciesMatthew L Cooper, Jaebok Choi, Karl Staser, et al.
Nature Communications|July 28, 2021
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth SyndromeAmanda M Smith, Taylor A LaValle, Marwan Shinawi, et al.
Plos One|November 14, 2014
Clonal architectures and driver mutations in metastatic melanomasLi Ding, Minjung Kim, Krishna L Kanchi, et al.
JACC. Cardiovascular Imaging|May 23, 2021
Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart FailureJakub Lagan, Erik B Schelbert, Josephine H Naish, et al.
Blood Advances|July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapiesArmin Ghobadi, Jack H Landmann, Alun Carter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pageof 24

Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Cell Reports|September 30, 2016
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary CarcinomasObi L Griffith, Szeman Ruby Chan, Malachi Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Clonal Hematopoiesis and Risk of Incident Lung CancerRuiyi Tian, Brian Wiley, Jie Liu, et al.
Leukemia|February 28, 2018
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignanciesMatthew L Cooper, Jaebok Choi, Karl Staser, et al.
Nature Communications|July 28, 2021
Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth SyndromeAmanda M Smith, Taylor A LaValle, Marwan Shinawi, et al.
Plos One|November 14, 2014
Clonal architectures and driver mutations in metastatic melanomasLi Ding, Minjung Kim, Krishna L Kanchi, et al.
JACC. Cardiovascular Imaging|May 23, 2021
Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart FailureJakub Lagan, Erik B Schelbert, Josephine H Naish, et al.
Blood Advances|July 20, 2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapiesArmin Ghobadi, Jack H Landmann, Alun Carter, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Pageof 24